Nedrow, Jessie R.
Latoche, Joseph D.
Day, Kathryn E.
Modi, Jalpa
Ganguly, Tanushree
Zeng, Dexing
Kurland, Brenda F.
Berkman, Clifford E.
Anderson, Carolyn J.
Funding for this research was provided by:
NIH/NCI (R01CA140617)
U.S. Department of Energy (DE-SC0008833)
Article History
First Online: 9 November 2015
<!--Emphasis Type='Bold' removed-->Compliance with Ethical Standards
:
: Dr. Berkman is the inventor on issued patents related to PSMA inhibitors described in this report and presently also serves as the CSO of Cancer Targeted Technology.